Neovascular (Wet) Age-Related Macular Degeneration
Ophthalmology·MeSH: Macular Degeneration
Prevalence
2000.0 / 100K
Incidence
200.0 / 100K/yr
4 drugs in development·3 companies·1 clinical trial
Drug Pipeline by Phase
Compare drugs
Frequently asked questions
How many drugs are in development for Neovascular (Wet) Age-Related Macular Degeneration?
BioSniper tracks 4 drugs in development for Neovascular (Wet) Age-Related Macular Degeneration across 3 companies.
How many clinical trials target Neovascular (Wet) Age-Related Macular Degeneration?
There are 1 clinical trial targeting Neovascular (Wet) Age-Related Macular Degeneration tracked by BioSniper.
What is the prevalence of Neovascular (Wet) Age-Related Macular Degeneration?
The estimated prevalence of Neovascular (Wet) Age-Related Macular Degeneration is approximately 2000.0 per 100,000 population.
Deep-dive into Neovascular (Wet) Age-Related Macular Degeneration
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis